Proof-of-concept study investigating AEZS 108 in pancreatic cancer.
Phase of Trial: Phase II
Latest Information Update: 15 Dec 2010
At a glance
- Drugs Zoptarelin doxorubicin (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors AEterna Zentaris Inc
- 15 Dec 2010 This trial is expected to be initiated in 2011, according to an Aeterna Zentaris media release.
- 15 Dec 2010 New trial record